HKSE - Delayed Quote HKD

CSPC Pharmaceutical Group Limited (1093.HK)

6.600 +0.080 (+1.23%)
At close: April 26 at 4:08 PM GMT+8
All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
4,178,815.000
4,178,815.000
7,627,064.000
4,636,627.000
6,739,610.000
Investing Cash Flow
607,267.000
607,267.000
-6,795,984.000
-637,326.000
-2,129,513.000
Financing Cash Flow
-2,300,981.000
-2,300,981.000
-1,904,073.000
-2,196,606.000
-1,470,976.000
End Cash Position
10,490,845.000
10,490,845.000
8,000,852.000
9,059,709.000
7,259,458.000
Capital Expenditure
-1,893,067.000
-1,893,067.000
-2,722,692.000
-1,758,448.000
-1,576,606.000
Issuance of Debt
--
--
485,712.000
--
169,000.000
Repayment of Debt
-27,840.000
-27,840.000
-495,712.000
-99,000.000
--
Repurchase of Capital Stock
-200,358.000
-200,358.000
-14,211.000
-263,512.000
--
Free Cash Flow
2,285,748.000
2,285,748.000
4,904,372.000
2,878,179.000
5,163,004.000
12/31/2020 - 5/13/2003

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

600276.SS Jiangsu Hengrui Medicine Co., Ltd.
45.61
+2.96%
 
1666.HK Tong Ren Tang Technologies Co. Ltd.
5.310
+7.71%
 
GSK.L GSK plc
1,653.00
+0.76%
 
ROG.SW Roche Holding AG
221.00
+1.01%
 
RHHBY Roche Holding AG
30.25
+0.77%
 
AZN AstraZeneca PLC
75.17
+0.19%
 
BMY Bristol-Myers Squibb Company
44.85
+0.34%
 
AZN.L AstraZeneca PLC
11,988.00
-0.32%
 
BIIB Biogen Inc.
208.90
+3.18%
 
NVS Novartis AG
97.44
-1.64%